1-(9-fluorenyl)ethyl chloroformate has been researched along with reboxetine in 1 studies
| Studies (1-(9-fluorenyl)ethyl chloroformate) | Trials (1-(9-fluorenyl)ethyl chloroformate) | Recent Studies (post-2010) (1-(9-fluorenyl)ethyl chloroformate) | Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) |
|---|---|---|---|---|---|
| 23 | 0 | 5 | 626 | 193 | 184 |
| Protein | Taxonomy | 1-(9-fluorenyl)ethyl chloroformate (IC50) | reboxetine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frigerio, E; Pianezzola, E; Strolin Benedetti, M | 1 |
1 other study(ies) available for 1-(9-fluorenyl)ethyl chloroformate and reboxetine
| Article | Year |
|---|---|
Sensitive procedure for the determination of reboxetine enantiomers in human plasma by reversed-phase high-performance liquid chromatography with fluorimetric detection after chiral derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Evaluation Studies as Topic; Fluorenes; Humans; Indicators and Reagents; Male; Morpholines; Reboxetine; Spectrometry, Fluorescence; Stereoisomerism | 1994 |